54 related articles for article (PubMed ID: 10449608)
1. Organised vs. spontaneous Pap-smear screening for cervical cancer: A case-control study.
Nieminen P; Kallio M; Anttila A; Hakama M
Int J Cancer; 1999 Sep; 83(1):55-8. PubMed ID: 10449608
[TBL] [Abstract][Full Text] [Related]
2. Social Inequalities in Participation in Cervical Cancer Screening in a Metropolitan Area Implementing a Pilot Organised Screening Programme (Paris Region, France).
Audiger C; Bovagnet T; Bardes J; Abihsera G; Nicolet J; Deghaye M; Bochaton A; Menvielle G
Int J Public Health; 2022; 67():1604562. PubMed ID: 35859669
[No Abstract] [Full Text] [Related]
3. Efficacy of patient letter reminders on cervical cancer screening: a meta-analysis.
Tseng DS; Cox E; Plane MB; Hla KM
J Gen Intern Med; 2001 Aug; 16(8):563-8. PubMed ID: 11556935
[TBL] [Abstract][Full Text] [Related]
4. Age-period-cohort analysis of cervical cancer incidence in Hong Kong from 1972 to 2001 using maximum likelihood and Bayesian methods.
Leung GM; Woo PP; McGhee SM; Cheung AN; Fan S; Mang O; Thach TQ; Ngan HY
J Epidemiol Community Health; 2006 Aug; 60(8):712-20. PubMed ID: 16840762
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum: Social Inequalities in Participation in Cervical Cancer Screening in a Metropolitan Area Implementing a Pilot Organised Screening Programme (Paris Region, France).
Audiger C; Bovagnet T; Bardes J; Abihsera G; Nicolet J; Deghaye M; Bochaton A; Menvielle G
Int J Public Health; 2022; 67():1605236. PubMed ID: 36275435
[TBL] [Abstract][Full Text] [Related]
6. Correction: Impact of organised colorectal cancer screening on age-specific population incidences: evidence from a quasi-experimental study in Sweden.
Strand GC; Strömberg U; Forsberg A; Bonander C
Eur J Epidemiol; 2024 May; ():. PubMed ID: 38709418
[No Abstract] [Full Text] [Related]
7. Self-sampling experiences among non-attendees to cervical screening.
Virtanen A; Nieminen P; Niironen M; Luostarinen T; Anttila A
Gynecol Oncol; 2014 Dec; 135(3):487-94. PubMed ID: 25284037
[TBL] [Abstract][Full Text] [Related]
8. Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival.
Kannegaard PN; van der Mark S; Eiken P; Abrahamsen B
Age Ageing; 2010 Mar; 39(2):203-9. PubMed ID: 20075035
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Cervical Testing in and outside a Screening Program-A Case-Control Study.
Pankakoski M; Sarkeala T; Anttila A; Heinävaara S
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358612
[TBL] [Abstract][Full Text] [Related]
10. Exposure Definition in Case-Control Studies of Cervical Cancer Screening: A Systematic Literature Review.
Castanon A; Kamineni A; Elfström KM; Lim AWW; Sasieni P
Cancer Epidemiol Biomarkers Prev; 2021 Dec; 30(12):2154-2166. PubMed ID: 34526301
[TBL] [Abstract][Full Text] [Related]
11. Never and under cervical cancer screening in Switzerland and Belgium: trends and inequalities.
Jolidon V; De Prez V; Willems B; Bracke P; Cullati S; Burton-Jeangros C
BMC Public Health; 2020 Oct; 20(1):1517. PubMed ID: 33028278
[TBL] [Abstract][Full Text] [Related]
12. Level and Factors Associated with Participation in Population-Based Cancer Screening in Safranbolu District of Karabuk, Turkey.
Özdemir R; TÜrkmen Çevik F; Kes D; Karacali M; ÖzgÜner S
Iran J Public Health; 2020 Apr; 49(4):663-672. PubMed ID: 32548046
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial.
van de Laar RLO; Hofhuis W; Duijnhoven RG; Polinder S; Melchers WJG; van Kemenade FJ; Bekkers RLM; Van Beekhuizen HJ
BMC Cancer; 2020 Jun; 20(1):539. PubMed ID: 32517663
[TBL] [Abstract][Full Text] [Related]
14. Cervical Cancer Screening Services at Tertiary Healthcare Facility: An Alternative Approach.
Dhanasekaran K; Verma C; Kumar V; Hariprasad R; Gupta R; Gupta S; Mehrotra R
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1265-1269. PubMed ID: 31030504
[TBL] [Abstract][Full Text] [Related]
15. The impact of regional screening policies on the diffusion of cancer screening participation in Belgium: time trends in educational inequalities in Flanders and Wallonia.
Willems B; Bracke P
BMC Health Serv Res; 2018 Dec; 18(1):943. PubMed ID: 30514273
[TBL] [Abstract][Full Text] [Related]
16. Moving towards an organized cervical cancer screening: costs and impact.
Diaz M; Moriña D; Rodríguez-Salés V; Ibáñez R; Espinás JA; de Sanjosé S
Eur J Public Health; 2018 Dec; 28(6):1132-1138. PubMed ID: 29684144
[TBL] [Abstract][Full Text] [Related]
17. Do Cervical Cancer Patients Diagnosed with Opportunistic Screening Live Longer? An Arkhangelsk Cancer Registry Study.
Roik EE; Nieboer E; Kharkova OA; Grjibovski AM; Postoev VA; Odland JØ
Int J Environ Res Public Health; 2017 Nov; 14(12):. PubMed ID: 29186874
[TBL] [Abstract][Full Text] [Related]
18. The Korean guideline for cervical cancer screening.
Min KJ; Lee YJ; Suh M; Yoo CW; Lim MC; Choi J; Ki M; Kim YM; Kim JW; Kim JH; Park EW; Lee HY; Lim SC; Cho CH; Hong SR; Dang JY; Kim SY; Kim Y; Lee WC; Lee JK
J Gynecol Oncol; 2015 Jul; 26(3):232-9. PubMed ID: 26197860
[TBL] [Abstract][Full Text] [Related]
19. Impact of opportunistic testing in a systematic cervical cancer screening program: a nationwide registry study.
Tranberg M; Larsen MB; Mikkelsen EM; Svanholm H; Andersen B
BMC Public Health; 2015 Jul; 15():681. PubMed ID: 26194007
[TBL] [Abstract][Full Text] [Related]
20. The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.
Nowakowski A; Cybulski M; Śliwczyński A; Chil A; Teter Z; Seroczyński P; Arbyn M; Anttila A
BMC Cancer; 2015 Apr; 15():279. PubMed ID: 25879466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
